Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7599)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2014 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bork U, Grützmann R, Rahbari NN, Schölch S, Distler M, Reissfelder C, Koch M, Weitz J. Prognostic relevance of minimal residual disease in colorectal cancer. World J Gastroenterol 2014; 20(30): 10296-10304 [PMID: 25132746 DOI: 10.3748/wjg.v20.i30.10296] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i30/10296.htm |
| Number | Citing Articles |
| 1 |
Sung Hwan Lee, Sang A Park, Yunyun Zou, Sang-Uk Seo, Chang-Duk Jun, Woo Jung Lee, Young-Min Hyun, Nam Hoon Cho. Real-Time Monitoring of Cancer Cells in Live Mouse Bone Marrow. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01681
|
| 2 |
Simran Grewal, Steven J. Oosterling, Marjolein van Egmond. Surgery for Colorectal Cancer: A Trigger for Liver Metastases Development? New Insights into the Underlying Mechanisms. Biomedicines 2021; 9(2): 177 doi: 10.3390/biomedicines9020177
|
| 3 |
Meiyi Xu, Tianhao Shi, Ruilian Xu, Gong Chen, Wan He. The potential role of minimal/molecular residual disease in colorectal cancer: curative surgery, radiotherapy and beyond. Journal of the National Cancer Center 2023; 3(3): 203 doi: 10.1016/j.jncc.2023.05.005
|
| 4 |
Gregor Norcic, Franc Jelenc, Petra Cerkovnik, Vida Stegel, Srdjan Novakovic. Role of specific DNA mutations in the peripheral blood of colorectal cancer patients for the assessment of tumor stage and residual disease following tumor resection. Oncology Letters 2016; 12(5): 3356 doi: 10.3892/ol.2016.5078
|
| 5 |
Lars Thomas Seeberg, Cathrine Brunborg, Anne Waage, Harald Hugenschmidt, Anne Renolen, Ingunn Stav, Bjørn A. Bjørnbeth, Elin Borgen, Bjørn Naume, Kristoffer W. Brudvik, Gro Wiedswang. Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases. Annals of Surgical Oncology 2017; 24(8): 2113 doi: 10.1245/s10434-017-5818-2
|
| 6 |
G.S. Banipal, B.V. Stimec, S.N. Andersen, A.E. Faerden, B. Edwin, J. Baral, J.M. Nesgaard, J. Šaltytė Benth, D. Ignjatovic, Tom Oresland, Arne O. Bakka, Yngve Thorsen, Anne Negaard, Russel Jacobsen, Kari Mette Langerød von Brandis, Tania Hansen, Pål Suhrke, Javier Luzon, Baris Sevinç, Bjarte Tidemann Andersen, Roberto Bergamaschi, Frieder Pullig, Ulrich Schneider, Marcos Gomez Ruiz, Erik Kjaestad, Vahid Bemanian, Anne Pernille H. Dyrbekk, Vladimir Zivanovic, Johannes Kurt Schultz, Knut Magne Augestad, Hanne Marie Hamre. Comparing 5-Year Survival Rates Before and After Re-stratification of Stage I–III Right-Sided Colon Cancer Patients by Establishing the Presence/Absence of Occult Tumor Cells and Lymph Node Metastases in the Different Levels of Surgical Dissection. Journal of Gastrointestinal Surgery 2022; 26(10): 2201 doi: 10.1007/s11605-022-05434-6
|
| 7 |
Jason Chibuk, Andi Flory, Kristina M. Kruglyak, Nicole Leibman, Alexis Nahama, Nilesh Dharajiya, Dirk van den Boom, Taylor J. Jensen, Jeffrey S. Friedman, M. Richard Shen, Francisco Clemente-Vicario, Ilya Chorny, John A. Tynan, Katherine M. Lytle, Lauren E. Holtvoigt, Muhammed Murtaza, Luis A. Diaz, Dana W. Y. Tsui, Daniel S. Grosu. Horizons in Veterinary Precision Oncology: Fundamentals of Cancer Genomics and Applications of Liquid Biopsy for the Detection, Characterization, and Management of Cancer in Dogs. Frontiers in Veterinary Science 2021; 8 doi: 10.3389/fvets.2021.664718
|
| 8 |
Marina A Senchukova. Colorectal cancer and dormant metastases: Put to sleep or destroy?. World Journal of Gastrointestinal Oncology 2024; 16(6): 2304-2317 doi: 10.4251/wjgo.v16.i6.2304
|
| 9 |
Hirotaka Momose, Kiichi Sugimoto, Takahiro Irie, Sachio Nomura, Hisashi Ro, Shun Ishiyama, Makoto Takahashi, Thomas Pisanic, Kazuhiro Sakamoto. Prognostic utility of circulating tumor DNA methylation analysis in stage IV colorectal cancer. Journal of Surgical Oncology 2024; doi: 10.1002/jso.27824
|
| 10 |
S. J. Schraa, K. L. van Rooijen, D. E. W. van der Kruijssen, C. Rubio Alarcón, J. Phallen, M. Sausen, J. Simmons, V. M. H. Coupé, W. M. U. van Grevenstein, S. Elias, H. M. Verkooijen, M. M. Laclé, L. J. W. Bosch, D. van den Broek, G. A. Meijer, V. E. Velculescu, R. J. A. Fijneman, G. R. Vink, M. Koopman, Mich S. Dunker, Martijn F. Lutke Holzik, Ronald Hoekstra, Dirkje W. Sommeijer, Jarmila D. W. van der Bilt, Esther C. J. Consten, Geert A. Cirkel, Thijs A. Burghgraef, Emma M. van der Schans, Peter Nieboer, Ron C. Rietbroek, Jan Willem T. Dekker, Arjan J. Verschoor, Koen A. K. Talsma, Rebecca P. M. Brosens, Helgi H. Helgason, Andreas W. K. S. Marinelli, Ignace H. J. T. de Hingh, Corina N. Oldenhuis, Jan Jansen, Henk K. van Halteren, Hein B. A. C. Stockmann, Aart Beeker, Koop Bosscha, Hans F. M. Pruijt, Leontine E. A. M. M. Spierings, Liselot B. J. Valkenburg-Van Iersel, Wouter J. Vles, Felix E. de Jongh, Hester van Cruijsen, Joost T. Heikens, David D. E. Zimmerman, Robert J. van Alphen, Anandi H. W. Schiphorst, Lobke L. van Leeuwen-Snoeks, Jeroen F. J. Vogelaar, Natascha A. J. B. Peters. Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07252-y
|
| 11 |
Sebastian Schölch, Sebastián A. García, Naoki Iwata, Thomas Niemietz, Alexander M. Betzler, Lahiri K. Nanduri, Ulrich Bork, Christoph Kahlert, May-Linn Thepkaysone, Anka Swiersy, Markus W. Büchler, Christoph Reissfelder, Jürgen Weitz, Nuh N. Rahbari. Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer. Oncotarget 2016; 7(19): 27232 doi: 10.18632/oncotarget.8373
|
| 12 |
Gholamreza Mohajeri, Kavak Hejab, Saba Sheikhbahaei, Mohammadreza Mohajeri, Negar Niknam, Alireza Mohammadi. Micrometastasis in colorectal cancer: does it affect staging?. ANZ Journal of Surgery 2018; 88(4) doi: 10.1111/ans.13809
|
| 13 |
Carlotta Ceccon, Valentina Angerilli, Cosimo Rasola, Letizia Procaccio, Marianna Sabbadin, Francesca Bergamo, Umberto Malapelle, Sara Lonardi, Matteo Fassan. Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.930108
|
| 14 |
Helena Caiado, Natércia Conceição, Daniel Tiago, Ana Marreiros, Susana Vicente, Jose Luis Enriquez, Ana Margarida Vaz, Artur Antunes, Horácio Guerreiro, Paulo Caldeira, M. Leonor Cancela. Evaluation of MGP gene expression in colorectal cancer. Gene 2020; 723: 144120 doi: 10.1016/j.gene.2019.144120
|
| 15 |
Elie El Rassy, Tarek Assi, Joseph Kattan. Is Minimal Residual Disease A Convincing Tool to Determine the Treatment Duration of Immune Checkpoint Inhibitors?. Future Oncology 2017; 13(5): 381 doi: 10.2217/fon-2016-0462
|
| 16 |
Martin Pesta, Vlastimil Kulda, Andrea Narsanska, Jakub Fichtl, Ondrej Topolcan. May CTC technologies promote better cancer management?. EPMA Journal 2015; 6(1) doi: 10.1186/s13167-014-0023-x
|
| 17 |
Yuhao He, Xinxin He, Yubo Zhou, Shanshan Luo. Clinical value of circulating tumor cells and hematological parameters in 617 Chinese patients with colorectal cancer: retrospective analysis. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11204-7
|
| 18 |
Raju K. Pillai, Jean R. Lopategui, Deepti Dhall, Maha Guindi, Thomas Slavin, Catherine E. Lofton-Day, Scott D. Patterson. The State of the Art in Colorectal Cancer Molecular Biomarker Testing. Advances in Anatomic Pathology 2016; 23(2): 92 doi: 10.1097/PAP.0000000000000107
|
| 19 |
Alberto Visioli, Fabrizio Giani, Nadia Trivieri, Riccardo Pracella, Elide Miccinilli, Maria Grazia Cariglia, Orazio Palumbo, Andrea Arleo, Fabio Dezi, Massimiliano Copetti, Laura Cajola, Silvia Restelli, Valerio Papa, Antonio Sciuto, Tiziana Pia Latiano, Massimo Carella, Dino Amadori, Giulia Gallerani, Riccardo Ricci, Sergio Alfieri, Graziano Pesole, Angelo L. Vescovi, Elena Binda. Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies. eBioMedicine 2019; 44: 346 doi: 10.1016/j.ebiom.2019.04.049
|
| 20 |
Lei Zhu, Barbara Hissa, Balázs Győrffy, Johann-Christoph Jann, Cui Yang, Christoph Reissfelder, Sebastian Schölch. Characterization of Stem-like Circulating Tumor Cells in Pancreatic Cancer. Diagnostics 2020; 10(5): 305 doi: 10.3390/diagnostics10050305
|
| 21 |
Ting Jiang, Kun Liu, Zexin Chen. The impact of perioperative red blood cell transfusion on the prognosis of colorectal cancer. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.927787
|
| 22 |
Chengguang Yang, Wenfang Zhuang, Yuemei Hu, Leiming Zhu. Clinical significance of peripheral circulating tumor cell counts in colorectal polyps and non-metastatic colorectal cancer. World Journal of Surgical Oncology 2018; 16(1) doi: 10.1186/s12957-017-1305-2
|
| 23 |
Qingxuan Wang, Endong Chen, Yefeng Cai, Chong Chen, Wenxu Jin, Zhouci Zheng, Yixiang Jin, Yao Chen, Xiaohua Zhang, Quan Li. Preoperative endoscopic localization of colorectal cancer and tracing lymph nodes by using carbon nanoparticles in laparoscopy. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0987-1
|
| 24 |
Nigel P. Murray. Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management. Biological Research 2018; 51(1) doi: 10.1186/s40659-018-0180-9
|
| 25 |
Lino Möhrmann, Martina K. Zowada, Hendrik Strakerjahn, Christine Siegl, Annette Kopp‐Schneider, Damir Krunic, Dirk Strunk, Martin Schneider, Mark Kriegsmann, Katharina Kriegsmann, Friederike Herbst, Claudia R. Ball, Hanno Glimm, Sebastian M. Dieter. A perivascular niche in the bone marrow hosts quiescent and proliferating tumorigenic colorectal cancer cells. International Journal of Cancer 2020; 147(2): 519 doi: 10.1002/ijc.32933
|
| 26 |
Nuh N. Rahbari, Sebastian Schölch, Ulrich Bork, Christoph Kahlert, Martin Schneider, Mohammad Rahbari, Markus W. Büchler, Jürgen Weitz, Christoph Reissfelder. Prognostic value of circulating endothelial cells in metastatic colorectal cancer. Oncotarget 2017; 8(23): 37491 doi: 10.18632/oncotarget.16397
|
| 27 |
Alexios-Fotios A. Mentis, Petros D. Grivas, Efthimios Dardiotis, Nicholas A. Romas, Athanasios G. Papavassiliou. Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal. Cellular and Molecular Life Sciences 2020; 77(18): 3671 doi: 10.1007/s00018-020-03529-4
|